Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network
- PMID: 34318925
- PMCID: PMC8881968
- DOI: 10.1002/cpt.2340
Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network
Abstract
The new Pharmacogenomics Global Research Network (PGRN) is an independent society that builds on the National Institutes of Health (NIH)–funded Pharmacogenomics Research Network that was established in 2000. Leveraging the original PGRN’s previous success, the new network continues to be a leader in the field of personalized medicine focusing on research, discovery, and translation of genomic variation influencing drug efficacy and adverse events, while simultaneously increasing inclusion in the field and expanding globally.
Conflict of interest statement
CONFLICT OF INTEREST
A.A.M. is the current President of the PGRN and a member of the PGRN Board of Directors. J.J.Y. is the President-Elect and L.B.R. is the Treasurer-Elect of the PGRN. K.M.G. is a past president of the PGRN and a past member of the PGRN Board of Directors. All authors are PGRN members.
Figures
References
-
- PGRN. Pharmacogenomics global research network <www.PGRN.org> (2020).
